Introduction

LyoGo was the first company founded out of the Biomedship program at Purdue University.  Three graduate students, Peter Greco, Rush Bartlett and Arthur Chlebowski originally named the company GlucaGo because they created the drug delivery system for the injection of glucagon for diabetics.  The idea was to create a better way to make glucagon to go or “GlucaGo.”  The three invested $30,000 of their own money to develop a working prototype.  The team then traveled the country going to different business plan competitions.  Of the 11 competitions that the team entered, they placed 1st in 7 of them and in the top 5 of the rest (see all LyoGo awards).  During this tour, the team gained much publicity, was awarded $20,000 from NASA and appeared in Fortune Magazine, the Big Ten Network and other publications.  By the end of the circuit, the team was able to raise $100,000 which was all put back into the company.

What we do

LyoGo was formed for the purpose of developing innovative drug delivery systems. LyoGo is focused on engineering delivery systems which offer a superior user experience, are intuitive to use, improve safety and sterility, and substantially reduce or eliminate the need for refrigeration at room temperature which improves storage and distribution of drugs. LyoGo develops systems for delivering drugs that are intentionally designed to easily fit into the established drug filling processes of leading pharmaceutical companies.

LyoGo drug delivery systems accommodate those drugs that are unstable in solution form and thus either need to be refrigerated or lyophilized (freeze dried) to be stored. Hence, Lyo or lyophilized products to Go or LyoGo. Many drug formulations on the market fall into this category. To remain stable prior to injection, these drugs are usually kept in a lyophilized form, as a powder, in a small glass vial. To deliver the drug, one must inject a liquid into this vial, manually mix the drug, and retract the solution prior to injecting the patient. This process leaves many opportunities for problems to occur, especially in emergency or other situations outside of a health care setting.

Our Product

LyoGo’s patent-pending mixing technology stores a lyophilized drug and the liquid diluents in two chambers which are kept separate by a solid barrier. The drug container is constructed with materials that have already been approved by the FDA to contact most APIs. The shape of the drug container fits into current drug filling and lyophilizing equipment in the pharmaceutical industry. These are key advantages in keeping costs down. The patent-pending two-chamber mixing mechanism can then be placed into several different types of drug delivery systems.

Our first product, the QuickStick is an injection system which packages the mixing mechanism in a compact, convenient, easy to use delivery system.